Status:
TERMINATED
Comparison of Xtreme CT and DXA Bone Densitometry
Lead Sponsor:
Massachusetts General Hospital
Conditions:
Bone Density
Eligibility:
All Genders
20-40 years
Brief Summary
Dual-energy x-ray absorptiometry (DXA) is currently the most widely used tool for determining bone density. However, most experts consider DXA an imperfect and intermediate technology. DXA is subject ...
Eligibility Criteria
Inclusion
- Adults age 20-40 years
Exclusion
- Pregnancy
- History of bone modifying diseases (hyperparathyroidism, Paget's, hyperthyroidism, renal failure, nephrolithiasis, liver disease, eating disorder)
- History of amenorrhea
- Use of chronic steroids for \>3 months
Key Trial Info
Start Date :
August 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 29 2018
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT01199991
Start Date
August 1 2010
End Date
June 29 2018
Last Update
March 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114